Rosa Sottile

9PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyFlow analysisInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 30, 2024
Engineered NKG2C + NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome.

Kyle B Lupo, M Kazim Panjwani, Sanam Shahid

|Aug 28, 2024
NaCl enhances CD8+ T cell effector functions in cancer immunotherapy.

Caterina Scirgolea, Rosa Sottile, Marco De Luca

|Aug 19, 2024
Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function.

Jean-Benoît Le Luduec, Theodota Kontopoulos, M Kazim Panjwani

|Dec 20, 2023
Multipass high-dimensional flow cytometry.

Enrico Lugli, Mario Roederer, Rosa Sottile

|Oct 04, 2023
Single-Cell Profiling Reveals a Naive-Memory Relationship between CD56 bright and Adaptive Human Natural Killer Cells.

M Kazim Panjwani, Simon Grassmann, Rosa Sottile

|May 17, 2023
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.

Kattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos

Pageof 2

Frequent Collaborators

5 joint publications

M Kazim Panjwani

5 joint publications

Katharine C Hsu

3 joint publications

Jean-Benoît Le Luduec

3 joint publications

Joseph C Sun